Just keep in mind that recombination is considered to be more common between different variants of the same virus, and there are also plenty of other mechanisms by which mutations in the virus occur. And even with recombination between two different versions of this virus, it only seems to be relatively recently that this is being identified as an important mechanism for this stage in the evolution of the virus, which has led to a particularly noteworthy variant more recently. Before this development, and pre-Omicron, the other important variants were considered most plausibly to have come from long-term infections within individuals giving a version of the virus plenty of opportunity to evolve inside them.
In any case, the virus is certainly responding to the circumstances in which it finds itself in, which these days means an increasingly complicated picture of human immunity from vaccination and previous infections. It has more incentive than ever to find ways around a chunk of that protection. We've also had a long period where new Omicron versions have evolved from previous Omicron versions, which is quite a bit of a different chain of evolution compared to previous variants, and is why we havent had a brand new variant name for ages. At some point we may get something that breaks this pattern and we'll get a different name for it as a result. Not sure if I've messed this explanation up a bit by avoiding jargon.
I dont recall hearing that lateral flow tests in common use were updated to cope better with Omicron, though I may have missed something.